Natsuko Tsuda Okita

机构：National Cancer Center Hospital East, Tokyo National Hospital · ORCID：0000-0002-3990-5048

发表论文 217 篇 · 总被引 2006 次 · h-index 26

代表论文

• Phase I study of pevonedistat combined with capecitabine and oxaliplatin in patients with platinum-refractory advanced gastric cancer (2025 · Scientific Reports · 被引 6)
• Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer (2025 · Future Oncology · 被引 4)
• Efficacy of radioactive hypoxia-targeting therapeutic agent 64Cu-ATSM on recurrent malignant glioma: a study protocol for a phase-III, investigator-sponsored, randomized controlled trial (2025 · Japanese Journal of Clinical Oncology · 被引 4)
• Association Between Immune‐Related Adverse Events and Treatment Outcomes in Advanced Gastric Cancer Patients Receiving Nivolumab Plus Chemotherapy: A Retrospective Study (2025 · Cancer Medicine · 被引 3)
• A safety trial of antibiotic fecal microbiota transplantation for esophageal and gastric cancer patients treated with immune checkpoint inhibitors (Biorich2 trial). (2025 · Journal of Clinical Oncology · 被引 2)
• Efficacy and safety results of tazemetostat in Japanese patients with advanced epithelioid sarcoma: The phase 2 TAZETTA trial (NCCH2107). (2026 · Journal of Clinical Oncology · 被引 1)